𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation

✍ Scribed by Ziv Ben-Ari; Romy Zemel; Anna Kazetsker; Gerald Fraser; Ran Tur-Kaspa

Book ID
119396094
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
63 KB
Volume
94
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus precore mutant infecti
Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
✍ Peter W. Angus; Stephen A. Locarnini; Geoffrey W. McCaughan; Robert M. Jones; Ja 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

The factors that predispose patients undergoing liver transplantation for hepatitis B virus (HBW disease to severe recurrence of infection are unclear. In this study we examined the effect of pretransplantation infection with HBV and precore variant strains of HBV on posttransplantation outcome and

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60